Aug 2026· Yonsei medical journal· Vol 67, pp. 772 - 779· 0 citations· 25 references
Medicine
TL;DR
Low-grade albuminuria may serve as an early biomarker of cardiovascular risk in otherwise healthy individuals, particularly in subgroups susceptible to hormonal or metabolic changes, and may be a practical tool for early risk stratification and prevention of CVD.
Abstract
Purpose We aimed to assess whether low-grade albuminuria, characterized by a low urinary albumin-to-creatinine ratio (UACR) within the normal range (<30 mg/g), could predict cardiovascular disease (CVD) risk in a low-risk general population, with an emphasis on sex- and menopause-specific differences. Materials and Methods We analyzed data from 1327 participants from the Korean Genome and Epidemiology Study, excluding individuals with known CVD or major chronic illnesses, who were followed up for a median of 6.37 years. The UACR was measured from spot urine samples and treated as a continuous variable. The cardiovascular outcomes included stroke, myocardial infarction, and angina. Cox proportional hazards models and restricted cubic spline analyses were used to assess the association between UACR and incident CVD, stratified by sex and menopausal status. Results No significant association was observed between UACR and CVD in men or premenopausal women. However, in postmenopausal women, UACR was significantly associated with incident CVD (adjusted hazard ratio 1.09; 95% confidence interval: 1.01–1.18 per 1 mg/g increase). Spline analyses revealed a clear dose–response relationship in postmenopausal women, whereas no such pattern was observed in the other subgroups. Covariate-stratified analyses suggested a potential interaction effect of body mass index, blood pressure, and lipid profile. Conclusion Low-grade albuminuria may serve as an early biomarker of cardiovascular risk in otherwise healthy individuals, particularly in subgroups susceptible to hormonal or metabolic changes. Routine UACR screening may be a practical tool for early risk stratification and prevention of CVD.
The findings should be interpreted as hypothesis-generating and suggest that adults without diabetes but with clustered metabolic abnormalities may warrant further longitudinal evaluation for kidney risk stratification.
Xiao-Han Xu, Shan-Hu Qiu, Xiao-Ying Zhou et al.· Journal of Endocrinological...· 0 citations
The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) is a novel biomarker that integrates atherogenic and atheroprotective lipoprotein profiles. We aimed to examine the prognostic significance of NHHR in patients with cardiorenal syndrome (CRS), a vulnerable population with...
Qiao-Yun Ge, Hao Jiang, H. Lu et al.· Medicine· 0 citations
AIM
Low-density lipoprotein cholesterol (LDL-C) is a major contributor to atherosclerotic cardiovascular disease (CVD). The waist-to-height ratio (WHtR) has been proposed as a practical marker of central obesity; however, evidence linking WHtR with incident high LDL-C levels in Japanese populations remains limited. Thi...
Takako Fujii, Shintaro Ishida, Makiko Abe et al.· Journal of atherosclerosis a...· 0 citations
Cardiovascular diseases (CVD) are the leading global causes of death and disability. The residual cholesterol inflammation index (RCII) and estimated glucose disposal rate (eGDR) reflect inflammatory-metabolic risk and insulin resistance, respectively. However, their combined predictive capacity remains unclear....
Guan-Nan Ai, Xi-Ze Wu, Yue Li et al.· BMC Cardiovascular Disorders· 0 citations
In T2DM, LDL-C burden and variability jointly identified patients at greater risk, especially for MI and cardiovascular mortality, especially in younger adults or longer-duration diabetes subgroups.
Dae-Jeong Koo, J. Park, Kyungdo Han et al.· Diabetes, obesity and metabo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.